Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects. [electronic resource]
- Expert opinion on pharmacotherapy Aug 2007
- 1985-98 p. digital
Publication Type: Journal Article; Review
1744-7666
10.1517/14656566.8.12.1985 doi
Atherosclerosis--prevention & control Cardiovascular Diseases--drug therapy Diabetes Mellitus, Type 2--drug therapy Drug Therapy, Combination Fatty Liver--drug therapy Humans Hypoglycemic Agents--adverse effects PPAR gamma--agonists Pioglitazone Randomized Controlled Trials as Topic Thiazolidinediones--adverse effects